Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem and NAC in Off-Pump CABG
NCT01771978Phase 3Unknown
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2002
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diltiazem, acetylcysteine in reperfusion injury (IRI), sponsored by Strasbourg University Hospital. Status: unknown.
02
Drugs
diltiazemacetylcysteine
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01771978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01771978.